Literature DB >> 9764607

Differential production of IL-10 by T cells and monocytes of HIV-infected individuals: association of IL-10 production with CD28-mediated immune responsiveness.

A Kumar1, J B Angel, M P Daftarian, K Parato, W D Cameron, L Filion, F Diaz-Mitoma.   

Abstract

Immune unresponsiveness in HIV-1 infection can result from impaired signals delivered by the costimulatory CD28-B7 pathway and the altered production of immunoregulatory cytokines, in particular IL-10, whose production is altered in HIV-1 infection. In this study we investigate IL-10 regulation in T cells and monocytes from HIV+ individuals, and its association with CD28-mediated T cell proliferation. IL-10 production as analysed in T cell- and monocyte-depleted peripheral blood mononuclear cells (PBMC), and by intracellular staining at the single-cell level, reveals a defect in IL-10 production by CD4+ and CD8+ T cells, whereas monocytes constitute the major IL-10-producing cell type. To investigate the impact of IL-10 on immune responsiveness, CD28-mediated proliferative responses in HIV+ individuals were correlated with PHA-induced IL-10 production. CD4+ T cells expressed CD28, yet exhibited markedly reduced CD28-mediated cell proliferation. This CD28-mediated CD4+ T cell proliferation was found to be inversely associated with the levels of PHA-induced IL-10 production and could be restored, at least in part, by anti-IL-10 antibodies. These results suggest that IL-10 production is differentially regulated in T cells and monocytes of HIV+ individuals, and that IL-10 may have a role in inducing immune unresponsiveness by modulating the CD28-B7 pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9764607      PMCID: PMC1905077          DOI: 10.1046/j.1365-2249.1998.00689.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  58 in total

1.  Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation.

Authors:  B L Levine; J D Mosca; J L Riley; R G Carroll; M T Vahey; L L Jagodzinski; K F Wagner; D L Mayers; D S Burke; O S Weislow; D C St Louis; C H June
Journal:  Science       Date:  1996-06-28       Impact factor: 47.728

2.  CD28 costimulation prevents cell death during primary T cell activation.

Authors:  P J Noel; L H Boise; J M Green; C B Thompson
Journal:  J Immunol       Date:  1996-07-15       Impact factor: 5.422

3.  Altered cytokine production and accessory cell function after HIV-1 infection.

Authors:  J Yoo; H Chen; T Kraus; D Hirsch; S Polyak; I George; K Sperber
Journal:  J Immunol       Date:  1996-08-01       Impact factor: 5.422

4.  CD8+ lymphocyte phenotype and cytokine production in long-term non-progressor and in progressor patients with HIV-1 infection.

Authors:  S Zanussi; C Simonelli; M D'Andrea; C Caffau; M Clerici; U Tirelli; P DePaoli
Journal:  Clin Exp Immunol       Date:  1996-08       Impact factor: 4.330

5.  Differential modulation of B7-1 and B7-2 isoform expression on human monocytes by cytokines which influence the development of T helper cell phenotype.

Authors:  W D Creery; F Diaz-Mitoma; L Filion; A Kumar
Journal:  Eur J Immunol       Date:  1996-06       Impact factor: 5.532

6.  Expression of IL-10, IL-4 and interferon-gamma in unstimulated and mitogen-stimulated peripheral blood lymphocytes from HIV-seropositive patients.

Authors:  F Diaz-Mitoma; A Kumar; S Karimi; M Kryworuchko; M P Daftarian; W D Creery; L G Filion; W Cameron
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

7.  IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-alpha.

Authors:  P M Daftarian; A Kumar; M Kryworuchko; F Diaz-Mitoma
Journal:  J Immunol       Date:  1996-07-01       Impact factor: 5.422

8.  Human immunodeficiency virus type 1 infection of CD4+ T cells down-regulates the expression of CD28: effect on T cell activation and cytokine production.

Authors:  O K Haffar; M D Smithgall; J G Wong; J Bradshaw; P S Linsley
Journal:  Clin Immunol Immunopathol       Date:  1995-12

9.  Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells.

Authors:  H Groux; M Bigler; J E de Vries; M G Roncarolo
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

10.  T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons.

Authors:  J Estaquier; T Idziorek; W Zou; D Emilie; C M Farber; J M Bourez; J C Ameisen
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

View more
  14 in total

1.  Monocyte-derived cytokines in multiple sclerosis.

Authors:  L G Filion; G Graziani-Bowering; D Matusevicius; M S Freedman
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

2.  Differential effects of HIV type 1 clade B and clade C Tat protein on expression of proinflammatory and antiinflammatory cytokines by primary monocytes.

Authors:  Nimisha Gandhi; Zainulabedin Saiyed; Samikkannu Thangavel; Jose Rodriguez; K V K Rao; Madhavan P N Nair
Journal:  AIDS Res Hum Retroviruses       Date:  2009-07       Impact factor: 2.205

3.  Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection.

Authors:  Elias A Said; Franck P Dupuy; Lydie Trautmann; Yuwei Zhang; Yu Shi; Mohamed El-Far; Brenna J Hill; Alessandra Noto; Petronela Ancuta; Yoav Peretz; Simone G Fonseca; Julien Van Grevenynghe; Mohamed R Boulassel; Julie Bruneau; Naglaa H Shoukry; Jean-Pierre Routy; Daniel C Douek; Elias K Haddad; Rafick-Pierre Sekaly
Journal:  Nat Med       Date:  2010-03-07       Impact factor: 53.440

4.  Nef protein of human immunodeficiency virus and lipopolysaccharide induce expression of CD14 on human monocytes through differential utilization of interleukin-10.

Authors:  David Creery; Jonathan B Angel; Susan Aucoin; William Weiss; William D Cameron; Francisco Diaz-Mitoma; Ashok Kumar
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

5.  Dysregulation of B7.2 (CD86) expression on monocytes of HIV-infected individuals is associated with altered production of IL-2.

Authors:  A Kumar; J B Angel; S Aucoin; W D Creery; M P Daftarian; D W Cameron; L Filion; F Diaz-Mitoma
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

Review 6.  The role of IL-10 in regulating immunity to persistent viral infections.

Authors:  Elizabeth B Wilson; David G Brooks
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

Review 7.  T-cell exhaustion in HIV infection.

Authors:  Mohamed El-Far; Rabih Halwani; Elias Said; Lydie Trautmann; Mehrnoosh Doroudchi; Loury Janbazian; Simone Fonseca; Julien van Grevenynghe; Bader Yassine-Diab; Rafick-Pierre Sékaly; Elias K Haddad
Journal:  Curr HIV/AIDS Rep       Date:  2008-02       Impact factor: 5.071

8.  Peripheral blood CCR4+CCR6+ and CXCR3+CCR6+CD4+ T cells are highly permissive to HIV-1 infection.

Authors:  Annie Gosselin; Patricia Monteiro; Nicolas Chomont; Felipe Diaz-Griffero; Elias A Said; Simone Fonseca; Vanessa Wacleche; Mohamed El-Far; Mohamed-Rachid Boulassel; Jean-Pierre Routy; Rafick-Pierre Sekaly; Petronela Ancuta
Journal:  J Immunol       Date:  2009-12-30       Impact factor: 5.422

9.  Enhanced inhibitory effect of ultra-fine granules of red ginseng on LPS-induced cytokine expression in the monocyte-derived macrophage THP-1 cells.

Authors:  Hyoung-Cheol Lee; Radhakrishnan Vinodhkumar; Jang W Yoon; Seong-Kyu Park; Chang-Won Lee; Hong-Yeoul Kim
Journal:  Int J Mol Sci       Date:  2008-08-07       Impact factor: 6.208

10.  T lymphocytes from chagasic patients are activated but lack proliferative capacity and down-regulate CD28 and CD3ζ.

Authors:  Nicolás A Giraldo; Natalia I Bolaños; Adriana Cuellar; Nubia Roa; Zulma Cucunubá; Fernando Rosas; Víctor Velasco; Concepción J Puerta; John M González
Journal:  PLoS Negl Trop Dis       Date:  2013-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.